| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $251K | — | — |
| R&D Expense | $17.6M | -1.3% | +30.4% |
| SG&A Expense | $5.3M | +6.4% | +9.4% |
| Operating Income | -$22.9M | -0.4% | -24.9% |
| Net Income | -$21.5M | -1.3% | -23.2% |
| EPS (Basic) | -$0.88 | -1.1% | +4.3% |
| EPS (Diluted) | -$0.88 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $25.5M | -10.4% | -54.4% |
| Short-term Investments | $97.5M | -14.4% | +7.4% |
| Current Assets | $129.5M | -13.1% | -14.0% |
| Total Assets | $148.9M | -12.1% | -34.0% |
| Current Liabilities | $11.1M | +3.3% | -16.3% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$62.0M | — | — |
| Capital Expenditures | $2.2M | — | — |
| Investing Cash Flow | $47.4M | — | — |
| Financing Cash Flow | $130K | — | — |
| Free Cash Flow | -$64.2M | — | — |
| +4.3% |
| $19.6M |
| -3.5% |
| -20.2% |
| Stockholders' Equity | $129.2M | -13.3% | -35.7% |